Drugs / AMG 119
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03392064 | Sep 2018 → Jan 2028 | small cell lung carcinoma | Amgen | Suspended | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 119 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03392064 ↗ |
| Route | Intravenous | “AMG 119 administered as a one-time intravenous infusion” NCT03392064 ↗ |